Novartis | NVS - PE Price to Earnings


Novartis reported $16.05 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Amgen USD 25.31 15.82 Dec/2025
AstraZeneca USD 27.29 5.8 Dec/2025
Bausch Health Companies USD 6.98 0.41 Dec/2025
Biogen USD 14.02 4.63 Dec/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Corcept Therapeutics USD 41.9 52.28 Dec/2025
Drreddys Laboratories INR 18.27 0.84 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Gilead Sciences USD 15.63 0.08 Dec/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
Glaxosmithkline GBP 11.93 6.46 Sep/2025
J&J USD 23.62 0.86 Dec/2025
Merck USD 13.92 5.08 Dec/2025
Novartis USD 15.74 0.15 Sep/2025
Novartis USD 16.05 2.92 Sep/2025
Pacira USD 29.24 6.15 Sep/2025
Perrigo USD 34.31 15.46 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
Phibro Animal Health 48.92 329.32 Sep/2024
Prestige Brands USD 15.31 3.1 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
Sanofi EUR 15.75 1.53 Dec/2025
Supernus Pharmaceuticals USD 39.11 17.08 Sep/2025
Zoetis USD 20.42 2.84 Dec/2025